Adverse Event Reporting News - Levaquin tablets and oral solution
Levaquin (levofloxacin) Injection, for Intravenous Use
Levaquin (levofloxacin in 5% dextrose) Injection, for Intravenous Use
WARNINGS AND PRECAUTIONS
Photosensitivity/Phototoxicity
Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions (e.g., burning, erythema, exudation, vesicles, blistering, edema) involving areas exposed to light (typically the face, “V” area of the neck, extensor surfaces of the forearms, dorsa of the hands), can be associated with the use of quinolones after sun or UV light exposure. Therefore, excessive exposure to these sources of light should be avoided. Drug therapy should be discontinued if photosensitivity/ phototoxicity occurs [See ADVERSE REACTIONS (6.3); PATIENT COUNSELING INFORMATION (17.3)]
Related Results
Levaquin approvalLevaquin doseNew indication for LevaquinOral solution levaquin approvedShort-course Levaquin approved
ADVERSE REACTIONS
Serious and Otherwise Important Adverse Reactions
Photosensitivity/Phototoxicity
Postmarketing Experience
Table
Skin and Subcutaneous Tissue Disorders–Photosensitivity/Phototoxicity Reaction [see WARNINGS and PRECAUTIONS (5.10)]
PATIENT COUNSELING INFORMATION
Serious and Potentially Serious Adverse Reactions
Photosensitivity/Phototoxicity
What are possible side effects of Levaquin?
Sun sensitivity (photosensitivity) …
COPYRIGHT 2008 Washington Information Source, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
